Eris Lifesciences publishes an investor presentation detailing domestic leadership, international expansion, and capabilities across R&D and manufacturing, with near-term revenue visibility from EU-CDMO and a strong insulin portfolio.
AI Assistant
ERIS Lifesciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.